CD36 and colorectal carcinoma: For instance, CD36 inhibits β-catenin/c-myc signaling by stimulating the proteasome-dependent ubiquitination of GPC4, subsequently suppressing the downstream aerobic glycolysis and tumorigenesis in CRC [31].